Compare Citigroup Inc. (C) vs Novo Nordisk A/S (NVO) Price & Performance

Citigroup Inc.Trade

Novo Nordisk A/STrade

Price performance (Past 24H)

Key statistics

Citigroup Inc. vs Novo Nordisk A/S — how do they compare? Citigroup Inc. trades at $135.73 (market cap $226.82B), while Novo Nordisk A/S trades at $46.08 (market cap $207.31B). The key difference: Citigroup Inc. and Novo Nordisk A/S are close in size by market cap, and Novo Nordisk A/S pays the higher dividend (3.76%). Which is the better fit depends on your goals.

	C	NVO
Market Cap	$226.82B	$207.31B
Sector	Financials	Health
52-Week High	$145.67	$63.98
52-Week Low	$92.59	$35.29
Dividend Yield	1.98%	3.76%
Enterprise Value	—	$222.02B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Citigroup Inc.

No Aura AI signal available yet.

Novo Nordisk A/S

Novo Nordisk (NVO) trades at $47.26, up 2.79% today, with a neutral technical signal and strong fundamentals including a P/E of 11.67 and net income margin of 35.35%. Recent Q2 2026 earnings beat expectations, but shares faced pressure from competitive concerns and pipeline setbacks. Cash flow remains robust with $10.81B net cash flow in 2025, while debt-to-asset ratio rose to 20.61% in 2024.

Outlook is mixed: solid profitability and analyst buy consensus (57.9%) support upside, but competition from Eli Lilly and pricing headwinds pose risks. Revenue growth is steady, with 2026 guidance lifted, yet investor sentiment is cautious amid operational challenges and high expectations for Wegovy pill performance.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

5 key checks before applying for a balance transfer credit card to save on interest and feesFool - Investing News · 4 days agoNeutral Paying a 3% balance transfer fee can save thousands by avoiding high credit card interest rates.Fool - Investing News · 4 days agoBullish View details →

NVO

Novo Nordisk downgraded to Sell on weak growth and operational issues despite strong semaglutide sales.Seeking Alpha · 4 days agoBearish View details →

About Citigroup Inc.

Citigroup Inc. is a diversified financial services holding company that provides a broad range of financial services to consumer and corporate customers. The Company services include investment banking, retail brokerage, corporate banking, and cash management products and services. Citigroup serves customers globally.

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.